🇺🇸 FDA
Patent

US 7413754

Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones

granted A61KA61K36/71A61P

Quick answer

US patent 7413754 (Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones) held by Bionorica AG expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Bionorica AG
Grant date
Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K36/71, A61P, A61P13/00, A61P13/02